AI assistant
Sending…
Lipocine Inc. — Director's Dealing 2015
Oct 2, 2015
35074_dirs_2015-10-02_201c02d4-1cdb-4574-add7-63ba55250269.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2015-09-30
Reporting Person: Patel Mahesh V. (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-30 | Common Stock | P | 2000 | $12 | Acquired | 885632 | Direct |
| 2015-09-30 | Common Stock | P | 700 | $11.6799 | Acquired | 886332 | Direct |
| 2015-09-30 | Common Stock | P | 1300 | $11.676 | Acquired | 887632 | Direct |
More from Lipocine Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
Jun 4
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Proxy Solicitation & Information Statement
2026
Apr 21
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2